Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
about
Feasibility of chemosensitivity testing in soft tissue sarcomasThe in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumoursHeterogeneity of chemosensitivity in esophageal cancer using ATP-tumor chemosensitivity assayDNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells.Overview of a chemoresponse assay in ovarian cancerMolecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapyResponse prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assayPrediction of individual response to anticancer therapy: historical and future perspectivesAdenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis.Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO study.Heterogeneity of tumor chemosensitivity in ovarian epithelial cancer revealed using the adenosine triphosphate-tumor chemosensitivity assayEffect of Chemotherapeutic Drugs on Caspase-3 Activity, as a Key Biomarker for Apoptosis in Ovarian Tumor Cell Cultured as Monolayer. A Pilot Study.Human glioma demonstrates cell line specific results with ATP-based chemiluminescent cellular proliferation assays.Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine.Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer.Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells.Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay.ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof.A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancerPredictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer.Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.A feasibility study of adenosine triphosphate-based chemotherapy response assay (ATP-CRA) as a chemosensitivity test for lung cancer.In vitro chemoresponse assay based on the intrinsic subtypes in breast cancer.
P2860
Q24796008-198E65F0-BC90-4FC1-8CB2-B0A32A94C95EQ24802219-E2BF72A1-E24C-409D-AE81-2F3D28842312Q28389114-8C5ABDF8-2DF0-47E3-A3AD-E5A3ABA36624Q33509648-CA0DBD48-8699-4560-97F4-550B56D57A1CQ34071625-B6DC1BED-B551-44A9-B942-938E1E7A4F86Q34122814-8AF29C48-3E54-4A3C-904A-E64C8A68CE3FQ34795754-B59B3F57-09D0-472A-93CE-06DCE9874A0DQ35024682-F6BB2B89-BAD9-447E-9DC4-110061842BFCQ35653726-2FCD70B5-079E-4B50-9FC7-D46576C1B2E3Q35689902-FAEF7C05-5A6E-41C7-BFFF-6A569D6E7E31Q35742276-20316F1D-9CEA-4420-8EBA-DF7D31DE81E9Q36358405-72E936DB-42ED-460E-81F4-8AC8D0756EFBQ37226839-AE52FFA0-F82D-4225-9048-CE758A3E448FQ37888461-A1DB7037-A974-48DA-85AF-D51E6F8CA430Q38692850-F273BF17-5E36-4CF7-8231-5ACE53574F29Q39398132-1B52A92C-1FE2-4CC7-BABD-8BB0DFB3CDCEQ39538285-C0AEBD61-5736-4F8E-B253-10AF9549CB70Q39765219-1F7DF9F2-C444-46EB-A7FF-0269EAED9CA1Q42670617-C9A6D6B2-364C-4541-A879-C0D24A13E05BQ46621184-BD340D88-CDFA-44FE-9803-9F7DB8175014Q47101130-EE00F1C3-FD03-4B50-8965-B0DB536CE5FFQ49963361-8B5FEB5B-60F5-4691-8D50-3C29BEE43A51Q54354615-AE9B4052-025C-468A-9519-343BAA006093
P2860
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@ast
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@en
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@nl
type
label
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@ast
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@en
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@nl
prefLabel
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@ast
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@en
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@nl
P2093
P2860
P356
P1433
P1476
Outcome of ATP-based tumor che ...... ed recurrent ovarian carcinoma
@en
P2093
Alan Lamont
Andrew C Hindley
Bernard R Higgins
Christian M Kurbacher
Ian A Cree
Louise A Knight
Michael H Neale
Pauline A Whitehouse
Richard Osborne
Sanjay Sharma
P2860
P2888
P356
10.1186/1471-2407-3-19
P407
P577
2003-07-03T00:00:00Z
P5875
P6179
1005286468